EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery

Charlotte Stutzmann, Jiaxi Peng, Zhaoguan Wu, Christopher Savoie, Isabelle Sirois, Pierre Thibault, Aaron R Wheeler, Etienne Caron

Cell Reports Methods · 2023

DOI: 10.1016/j.crmeth.2023.100511 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Reports Methods, 2023. Verfasst von Charlotte Stutzmann und 7 weiteren Autor:innen. Beteiligte Einrichtung: CHU Sainte Justine Research Center, Montreal, QC, Canada. Hauptthemen laut MEDLINE: Microfluidics, Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research, FRQS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The identification of tumor-specific antigens (TSAs) is critical for developing effective cancer immunotherapies. Mass spectrometry (MS)-based immunopeptidomics has emerged as a powerful tool for identifying TSAs as physical molecules. However, current immunopeptidomics platforms face challenges in measuring low-abundance TSAs in a precise, sensitive, and reproducible manner from small needle-tissue biopsies (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrofluidicsNeoplasmsHumansMass SpectrometryHistocompatibility Antigens Class IHLA AntigensAntigens, Neoplasm

Stichwörter der Autor:innen

HLAMHCimmunopeptidomicsmass spectrometrymicrofluidicspeptidesingle-cell proteomics

Substanzen

Histocompatibility Antigens Class IHLA AntigensAntigens, Neoplasm

Autor:innen und Institutionen

  • CHU Sainte Justine Research Center, Montreal, QC, Canada.
  • Department of Chemistry, University of Toronto, Toronto, ON, Canada.
  • Institute for Research in Immunology and Cancer, University of Montreal, Montreal, QC, Canada.
  • Department of Chemistry, University of Montreal, Montreal, QC, Canada.
  • Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada.
  • Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada.

Förderung

  • CIHR
  • Canadian Institutes of Health Research
  • FRQS
  • Chung Hua University
  • Cole Foundation
  • Natural Sciences and Engineering Research Council of Canada
  • Fondation Charles-Bruneau
  • CQDM

Zitieren

APA

Stutzmann, C., Peng, J., Wu, Z., Savoie, C., Sirois, I., Thibault, P., Wheeler, A. R., & Caron, E. (2023). Unlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery. Cell Reports Methods. https://doi.org/10.1016/j.crmeth.2023.100511

Vancouver

Stutzmann C, Peng J, Wu Z, Savoie C, Sirois I, Thibault P, et al. Unlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery. Cell Reports Methods. 2023. doi:10.1016/j.crmeth.2023.100511

BibTeX
@article{Stutzmann2023,
  author = {Stutzmann, Charlotte and Peng, Jiaxi and Wu, Zhaoguan and Savoie, Christopher and Sirois, Isabelle and Thibault, Pierre and Wheeler, Aaron R and Caron, Etienne},
  title = {Unlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery},
  journal = {Cell Reports Methods},
  year = {2023},
  doi = {10.1016/j.crmeth.2023.100511}
}
Kostenlos starten →